VRDNViridian Therapeutics, Inc.\DE同业对比
Viridian Therapeutics, Inc.\DE 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRDN本股 | $2.8B#8 | — | 4.3x#5 | 40.2x#6 | 23359.9%#1 | -26.9%#9 | -512.9%#6 | -51.7%#10 | -54.5%#5 | — | 8.6%#2 | — |
| DYN | $3.4B#1 | — | 4.8x#8 | — | — | -40.6%#12 | — | -0.0%#2 | -1301.5%#9 | — | — | — |
| VKTX | $3.3B#2 | — | 5.7x#12 | — | — | -227.1%#15 | — | -61.1%#12 | — | — | — | — |
| ELVN | $3.3B#3 | — | 3.7x#4 | — | — | -16.5%#7 | — | -11.6%#4 | — | — | — | — |
| AMLX | $3.3B#4 | — | 13.6x#14 | — | -100.0%#9 | 52.0%#4 | — | -60.5%#11 | — | — | — | — |
| IRON | $3.1B#5 | — | 4.8x#9 | — | — | -94.0%#13 | — | -32.9%#8 | -39.0%#4 | — | — | — |
| BHC | $3.0B#6 | — | — | 0.3x#1 | 6.7%#5 | 441.3%#1 | 17.7%#2 | — | 3.7%#2 | — | — | 11.7%#1 |
| IDYA | $3.0B#7 | — | 2.8x#2 | 13.8x#3 | 3024.4%#2 | 58.6%#3 | -72.8%#3 | -10.4%#3 | — | — | — | — |
| NRIX | $2.8B#9 | 10.6x#1 | 2.9x#3 | 33.6x#5 | 54.0%#3 | -36.6%#10 | -340.2%#5 | -27.3%#7 | — | — | 104.8%#1 | — |
| MBX | $2.7B#10 | — | 6.5x#13 | — | — | -40.5%#11 | — | -21.2%#6 | — | — | — | — |
| RCUS | $2.4B#11 | — | 5.2x#10 | 73.0x#7 | -35.3%#8 | -24.7%#8 | -1169.7%#7 | -76.1%#14 | -93.0%#8 | — | — | — |
| PBH | $2.3B#12 | 13.9x#2 | 1.2x#1 | 2.2x#2 | -4.3%#6 | -11.3%#6 | 28.4%#1 | 9.9%#1 | 5.9%#1 | 4#1 | -18.2%#3 | — |
| IMNM | $2.3B#13 | — | 4.4x#6 | 332.7x#8 | -23.2%#7 | 27.5%#5 | -3228.8%#8 | -40.4%#9 | -72.8%#7 | — | — | — |
| XNCR | $2.3B#14 | — | 4.5x#7 | 18.2x#4 | 13.7%#4 | 60.5%#2 | -141.4%#4 | -18.3%#5 | -31.5%#3 | — | — | — |
| VERA | $2.2B#15 | — | 5.4x#11 | — | — | -96.9%#14 | — | -73.5%#13 | -72.7%#6 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议